CVS Health Corp (NYSE: CVS) started the day on Wednesday, with a price decrease of -3.01% at $71.15, before settling in for the price of $73.36 at the close. Taking a more long-term approach, CVS posted a 52-week range of $64.41-$83.25.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 13.36% over the last 5 years. Nevertheless, stock’s Earnings Per Share (EPS) this year is -5.16%. This publicly-traded company’s shares outstanding now amounts to $1.29 billion, simultaneously with a float of $1.26 billion. The organization now has a market capitalization sitting at $89.54 billion. At the time of writing, stock’s 50-day Moving Average stood at $75.85, while the 200-day Moving Average is $72.74.
CVS Health Corp (CVS) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Healthcare Plans Industry. CVS Health Corp’s current insider ownership accounts for 0.19%, in contrast to 82.35% institutional ownership. According to the most recent insider trade that took place on Feb 16 ’24, this organization’s EVP and Pres-Pharm, Consumer W sold 29,473 shares at the rate of 76.95, making the entire transaction reach 2,267,947 in total value, affecting insider ownership by 39,765. Preceding that transaction, on Nov 03 ’23, Company’s Director bought 2,000 for 70.47, making the whole transaction’s value amount to 140,930. This particular insider is now the holder of 20,630 in total.
CVS Health Corp (CVS) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 12/30/2023, the organization reported $2.12 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at $1.99) by $0.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.22 per share during the current fiscal year.
CVS Health Corp’s EPS decrease for this current 12-month fiscal period is -5.16% and is forecasted to reach 9.17 in the upcoming year.
CVS Health Corp (NYSE: CVS) Trading Performance Indicators
Let’s observe the current performance indicators for CVS Health Corp (CVS). It’s Quick Ratio in the last reported quarter now stands at 0.63. The Stock has managed to achieve an average true range (ATR) of 1.81. Alongside those numbers, its PE Ratio stands at $11.00, and its Beta score is 0.52. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.25. Similarly, its price to free cash flow for trailing twelve months is now 8.61.
In the same vein, CVS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 6.47, a figure that is expected to reach 1.71 in the next quarter, and analysts are predicting that it will be 9.17 at the market close of one year from today.
Technical Analysis of CVS Health Corp (CVS)
If we take a close look at the recent performances of CVS Health Corp (NYSE: CVS), its last 5-days Average volume was 6.6 million that shows plunge from its year to date volume of 11.07 million. During the previous 9 days, stock’s Stochastic %D was recorded 15.76% While, its Average True Range was 1.88.
Raw Stochastic average of CVS Health Corp (CVS) in the period of the previous 100 days is set at 26.84%, which indicates a major rise in contrast to 3.13% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 33.71% that was higher than 24.48% volatility it exhibited in the past 100-days period.
